Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1986 2
1989 1
1993 1
2006 2
2008 1
2009 1
2010 1
2011 1
2012 3
2013 2
2014 4
2015 7
2016 5
2017 4
2018 7
2019 3
2020 5
2021 3
2022 8
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
[Innovative ultrasound-based diagnosis of renal tumors].
Stock KF, Slotta-Huspenina J, Kübler H, Autenrieth M. Stock KF, et al. Among authors: autenrieth m. Urologe A. 2019 Dec;58(12):1418-1428. doi: 10.1007/s00120-019-01066-y. Urologe A. 2019. PMID: 31773181 Review. German.
[c-MET Oncogene in Renal Cell Carcinomas].
Erlmeier F, Weichert W, Autenrieth M, Ivanyi P, Hartmann A, Steffens S. Erlmeier F, et al. Among authors: autenrieth m. Aktuelle Urol. 2016 Dec;47(6):475-479. doi: 10.1055/s-0042-115401. Epub 2016 Dec 22. Aktuelle Urol. 2016. PMID: 28006830 Review. German.
WITHDRAWN: Immunotherapy for advanced renal cell cancer.
Coppin C, Porzsolt F, Autenrieth M, Kumpf J, Coldman A, Wilt TJ. Coppin C, et al. Among authors: autenrieth m. Cochrane Database Syst Rev. 2015 Dec 29;2015(12):CD001425. doi: 10.1002/14651858.CD001425.pub3. Cochrane Database Syst Rev. 2015. PMID: 26713838 Free PMC article. Review.
Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma.
Mikuteit M, Zschäbitz S, Erlmeier M, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F. Mikuteit M, et al. Among authors: autenrieth m. Oncology. 2022;100(10):536-541. doi: 10.1159/000525601. Epub 2022 Jun 27. Oncology. 2022. PMID: 35760058 Free PMC article.
Prognostic impact of PD-1 and its ligands in renal cell carcinoma.
Erlmeier F, Weichert W, Schrader AJ, Autenrieth M, Hartmann A, Steffens S, Ivanyi P. Erlmeier F, et al. Among authors: autenrieth m. Med Oncol. 2017 Jun;34(6):99. doi: 10.1007/s12032-017-0961-y. Epub 2017 Apr 21. Med Oncol. 2017. PMID: 28432616 Review.
c-Met in chromophobe renal cell carcinoma.
Erlmeier F, Ivanyi P, Hartmann A, Autenrieth M, Wiedemann M, Weichert W, Steffens S. Erlmeier F, et al. Among authors: autenrieth m. Med Oncol. 2017 Feb;34(2):15. doi: 10.1007/s12032-016-0874-1. Epub 2016 Dec 29. Med Oncol. 2017. PMID: 28035577
The role of claudin-6 in chromophobe renal cell carcinoma.
Erlmeier F, Zschäbitz S, Mikuteit M, Autenrieth M, Weichert W, Hartmann A, Steffens S. Erlmeier F, et al. Among authors: autenrieth m. Histol Histopathol. 2023 Apr;38(4):403-407. doi: 10.14670/HH-18-520. Epub 2022 Sep 21. Histol Histopathol. 2023. PMID: 36128931
The synergism of spatial metabolomics and morphometry improves machine learning-based renal tumour subtype classification.
Prade VM, Sun N, Shen J, Feuchtinger A, Kunzke T, Buck A, Schraml P, Moch H, Schwamborn K, Autenrieth M, Gschwend JE, Erlmeier F, Hartmann A, Walch A. Prade VM, et al. Among authors: autenrieth m. Clin Transl Med. 2022 Feb;12(2):e666. doi: 10.1002/ctm2.666. Clin Transl Med. 2022. PMID: 35184396 Free PMC article. No abstract available.
56 results